<?xml version="1.0" encoding="UTF-8"?>
<p id="p0090">A third type of vaccines is the VLP or virus-like particle. In this instance, surface proteins of the virion that can self-assemble into a structure like the original virus are constructed to elicit immune response, often with the aid of an adjuvant. Such VLP vaccines are difficult to design and manufacture. To date VLPs have been licensed against only the hepatitis E virus and human papillomavirus.</p>
